AI and MedTech Bring Precision Care Closer

Across Southeast Europe, new medical technologies are increasingly becoming part of everyday clinical practice. Magna MedTech Group operates at the point where global innovation meets local healthcare, connecting international manufacturers of medical equipment, diagnostic platforms and digital health solutions with public and private institutions across the region. According to the company figures reported by Investitor.me, the network works with more than 5,000 clients, employs over 800 specialists and reaches markets representing more than 94 million people.
From AI-enabled laboratories to precision therapy
The group’s portfolio spans laboratory diagnostics, radiology, surgery, cardiology, nephrology, oncology, intensive care and pathology. Digital health and artificial intelligence have a prominent role because they can help professionals process data more quickly, interpret findings more precisely and organize clinical workflows more efficiently. One example is WASPLab®, an automated microbiology system covering the workflow from sample reception to AI-supported interpretation of microbiological cultures. In oncology, Magna MedTech companies also support the installation and commissioning of advanced radiotherapy equipment. A highlighted regional project is the TrueBeam linear accelerator at the Military Medical Academy in Belgrade.
Technology supported throughout its life cycle
The regional model goes beyond equipment delivery. It includes planning, installation, staff training, maintenance and long-term technical and professional support. This approach recognizes that sophisticated technology produces meaningful results only when healthcare teams can integrate it safely and confidently into routine practice. The group therefore invests in practical programmes for clinicians and laboratory professionals, including training based on real clinical cases and specialist events that bring together local and international experts.
A regional network with local knowledge
Magna MedTech is active in Romania, Serbia, Bulgaria, Croatia, Montenegro, North Macedonia, Albania, Moldova, Ukraine and Kosovo, with entry into Greece planned. In Montenegro, the group is represented through Urion, a medical equipment distributor founded in 1999. The larger network gives local companies access to broader expertise, international partnerships and a wider range of technologies while preserving their understanding of local health systems and patient needs.
Why this matters for AI2MED
This regional development reflects a central challenge for AI in medicine: innovation must move responsibly from research and technology into real clinical environments. Successful adoption depends not only on algorithms and devices, but also on trained people, reliable infrastructure, continued evaluation and equitable access. By combining AI-supported diagnostics, advanced treatment technologies and local expertise, initiatives across Southeast Europe can help translate digital innovation into more timely, precise and accessible patient care.